Phuong N. Huynh

Array ( [id] => 6884682 [patent_doc_number] => 20010038842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'Methods for treating various cancers expressing vascular endothelial growth factor D, for screening for a neoplastic disease and for maintaining vascularization of tissue' [patent_app_type] => new [patent_app_number] => 09/796714 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15119 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20010038842.pdf [firstpage_image] =>[orig_patent_app_number] => 09796714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065514 [patent_doc_number] => 20010044418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Treatment of allergies' [patent_app_type] => new [patent_app_number] => 09/798075 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10685 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044418.pdf [firstpage_image] =>[orig_patent_app_number] => 09798075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 553576 [patent_doc_number] => 07157084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Extracellular serine protease' [patent_app_type] => utility [patent_app_number] => 09/796294 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 10938 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157084.pdf [firstpage_image] =>[orig_patent_app_number] => 09796294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 462576 [patent_doc_number] => 07238374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Process and substances for the release of a growth-regulating factor from endothelial cells' [patent_app_type] => utility [patent_app_number] => 09/788888 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 8682 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238374.pdf [firstpage_image] =>[orig_patent_app_number] => 09788888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032851 [patent_doc_number] => 20020019029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Wnt10a polynucleotides, Wint10a polypeptides and uses thereof' [patent_app_type] => new [patent_app_number] => 09/781867 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9423 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019029.pdf [firstpage_image] =>[orig_patent_app_number] => 09781867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5815202 [patent_doc_number] => 20020040015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'Methods and compositions for treating conditions of the eye' [patent_app_type] => new [patent_app_number] => 09/780142 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13274 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20020040015.pdf [firstpage_image] =>[orig_patent_app_number] => 09780142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323998 [patent_doc_number] => 20020197266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Immunotherapy using interleukin 13 receptor subunit alpha 2' [patent_app_type] => new [patent_app_number] => 09/780926 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17093 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197266.pdf [firstpage_image] =>[orig_patent_app_number] => 09780926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 933879 [patent_doc_number] => 06977074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'Method of inducing a CTL response' [patent_app_type] => utility [patent_app_number] => 09/776232 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 23923 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977074.pdf [firstpage_image] =>[orig_patent_app_number] => 09776232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778628 [patent_doc_number] => 20030049709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Programmed cell death and Ich-3' [patent_app_type] => new [patent_app_number] => 09/773670 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25036 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049709.pdf [firstpage_image] =>[orig_patent_app_number] => 09773670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 455691 [patent_doc_number] => 07244427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Isolated bovine IgG heavy chain protein and its use as an antimicrobial' [patent_app_type] => utility [patent_app_number] => 09/772603 [patent_app_country] => US [patent_app_date] => 2001-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3036 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244427.pdf [firstpage_image] =>[orig_patent_app_number] => 09772603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951326 [patent_doc_number] => 20020006639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Disease-associated gene' [patent_app_type] => new [patent_app_number] => 09/768436 [patent_app_country] => US [patent_app_date] => 2001-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13207 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006639.pdf [firstpage_image] =>[orig_patent_app_number] => 09768436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 723317 [patent_doc_number] => 07045133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor' [patent_app_type] => utility [patent_app_number] => 09/761636 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 60 [patent_no_of_words] => 14502 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045133.pdf [firstpage_image] =>[orig_patent_app_number] => 09761636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892049 [patent_doc_number] => 20010018211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Anti-proliferation domain of human Bcl-2 and DNA encoding the same' [patent_app_type] => new [patent_app_number] => 09/759136 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9959 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018211.pdf [firstpage_image] =>[orig_patent_app_number] => 09759136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874967 [patent_doc_number] => 20020049247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Novel treatment for eye disease' [patent_app_type] => new [patent_app_number] => 09/760362 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5679 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049247.pdf [firstpage_image] =>[orig_patent_app_number] => 09760362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5950778 [patent_doc_number] => 20020006402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Administering IgE antagonists during pregnancy to ameliorate allergic diseases in the offspring' [patent_app_type] => new [patent_app_number] => 09/759658 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3553 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006402.pdf [firstpage_image] =>[orig_patent_app_number] => 09759658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847351 [patent_doc_number] => 20030166518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Method for allergen characterization' [patent_app_type] => new [patent_app_number] => 09/759967 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10953 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166518.pdf [firstpage_image] =>[orig_patent_app_number] => 09759967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242102 [patent_doc_number] => 20020045186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Inhibition of protein binding to mast cells' [patent_app_type] => new [patent_app_number] => 09/756899 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3361 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045186.pdf [firstpage_image] =>[orig_patent_app_number] => 09756899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890524 [patent_doc_number] => 20010007755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases' [patent_app_type] => new-utility [patent_app_number] => 09/755132 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4917 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007755.pdf [firstpage_image] =>[orig_patent_app_number] => 09755132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7028041 [patent_doc_number] => 20010014456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-16 [patent_title] => 'Binding molecules for human factor VIII and factor VIII-like proteins' [patent_app_type] => new [patent_app_number] => 09/756594 [patent_app_country] => US [patent_app_date] => 2001-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11245 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20010014456.pdf [firstpage_image] =>[orig_patent_app_number] => 09756594 [rel_patent_id] =>[rel_patent_doc_number] =>)